Melinda Richter
Global Head of JLabs at Johnson & Johnson Innovation
Meet Melinda Richter
“Improving access to medicines starts with shortening the amount of time it takes to get a therapeutic into the hands of the patient or consumer. Typically, that process can take up to ten years and millions or even billions of dollars. This has to change!”
Before joining JLABS, Richter was the Founder and CEO of Prescience International, which was dedicated to accelerating research to the patient. Richter created the company after a medical emergency left her questioning the efficiency of the current healthcare system. In her current role, she supports the innovation community by creating capital-efficient commercialization models that help early-stage companies.